JAIDS: Journal of Acquired Immune Deficiency Syndromes

Articles Available on Medscape

• Impact of Antiretroviral Regimen on Pregnancy and Infant Outcomes in Women With HIV/HBV Coinfection
  Are certain ART regimens associated with a greater risk of adverse outcomes among pregnant women with HIV/HBV? Find out what there is to know.

  September 05, 2022

• A Demedicalized Model to Provide PrEP in a Sexual Health Clinic
  Could the implementation of this program help improve HIV PrEP uptake and retention among high-risk groups?

  August 31, 2022

• Factors Associated With Severity of COVID-19 Disease in a Multicenter Cohort of People With HIV in the United States, March-December 2020
  Learn more about the risk factors associated with COVID-19 severity among people living with HIV.

  July 20, 2022

• Pharmacokinetics of Tenofovir Alafenamide With Boosted Protease Inhibitors in Pregnant and Postpartum Women Living With HIV
  Do the results from this study support the use of this combination HIV treatment during the pregnancy and postpartum period?

  July 12, 2022

• Safety and Tolerability of Once Daily Coformulated Bictegravir, Emtricitabine, and Tenofovir Alafenamide for Postexposure Prophylaxis After Sexual Exposure
  Is this PEP regimen a safe and effective means of preventing HIV infection after high-risk sexual exposure?

  April 27, 2022

• Lower Incidence of HIV-1 Blips Observed During Integrase Inhibitor-Based Combination Antiretroviral Therapy
  A new study observes a lower number of viral blips during INSTI-based treatment compared with other ART regimens.

  March 30, 2022

• Bictegravir/Emtricitabine/Tenofovir Alafenamide Efficacy in Participants With Preexisting Primary Integrase Inhibitor Resistance Through 48 Weeks of Phase 3 Clinical Trials
  Is this HIV treatment option an effective means of achieving virologic suppression among those who are resistant to INSTI-based regimens?

  March 10, 2022

• Pharmacokinetics of Atazanavir Boosted With Cobicistat in Pregnant and Postpartum Women With HIV
  Is this ART regimen a safe HIV treatment during pregnancy?

  March 03, 2022

• Single Oral Doses of MK-8507, a Novel Non-Nucleoside Reverse Transcriptase Inhibitor, Suppress HIV-1 RNA for a Week
  A novel non-nucleoside reverse transcriptase inhibitor currently in development shows exciting potential as an oral treatment for HIV.

  February 07, 2022

• SARS-CoV-2 Infection Among People Living With HIV Compared With People Without HIV
  In what ways do the symptoms, severity, and outcomes of SARS-CoV-2 infection differ between people with and without HIV?

  December 24, 2021

• Sociodemographic Correlates of Self-Reported Discrimination in HIV Health Care Settings Among Persons With Diagnosed HIV in the United States, Medical Monitoring Project, 2018-2019
  A better understanding of the sociodemographic factors associated with HIV-related discrimination in health care settings could help guide future interventions to address this issue.

  November 30, 2021

• Multicenter Study of Outcomes Among Persons With HIV Who Presented to US Emergency Departments With Suspected SARS-CoV-2
  What have we learned about the clinical characteristics and outcomes of people with HIV and SARS-CoV-2 infection? A study of emergency department patients provides some insight.

  November 17, 2021

• Five Years With Dolutegravir Plus Lamivudine as a Switch Strategy
  A new study provides valuable insight into the safety and long-term efficacy of this combination regimen as a switch strategy in HIV patients.

  November 02, 2021

• HIV Infection Prevalence Significantly Intersects With COVID-19 Infection At the Area Level
  A new analysis finds a strong overlap between these infectious diseases at the geographical level, highlighting the need for more focused vaccination and prevention interventions in hard hit areas.

  September 27, 2021

• COVID-19 Testing, Characteristics, and Outcomes Among People Living With HIV in an Integrated Health System
  How do the rates of COVID-19 testing and complications among individuals with HIV differ from that of HIV-uninfected patients?

  September 13, 2021

• Early Diagnosis of HIV-1 and HIV-2 Using Cobas HIV-1/HIV-2 Qualitative Test
  How accurate is this test for the early detection and differentiation of HIV-1 and HIV-2?

  July 27, 2021

• High Levels of Prevention-Effective Adherence to HIV PrEP
  An analysis of data from a large PrEP trial finds high levels of prevention-effective adherence when considering sexual behavior and HIV risk during the trial period.

  July 13, 2021

• A Randomized Trial of a Brief Behavioral Intervention for PrEP Uptake Among Men Who Have Sex With Men at Increased Risk for HIV Infection
  A novel behavioral intervention may help increase PrEP uptake among men who have sex with men who are at a higher risk for HIV.

  July 01, 2021

• Acute HIV at the Time of Initiation of Pre-Exposure or Post-Exposure Prophylaxis
  Could undiagnosed HIV at the time of PrEP or PEP initation lead to antiretroviral resistance?

  June 07, 2021

• Changes in Sexual Behavior, PrEP Adherence, and Access to Sexual Health Services Because of the COVID-19 Pandemic Among a Cohort of PrEP-Using MSM in the South
  In what ways has the COVID-19 pandemic impacted the behaviors of PrEP-using MSM and their utilization of HIV services?

  April 27, 2021